Different effects of intervention: We simulate an intervention that decreases the nosocomial transmission rate by a factor of 70% (<i>β</i>→0.3<i>β</i>) starting from January 2011.... by Tal T. Robin (17847380)

NCOA4 protein expression is downregulated and GPX4 protein expression was significantly upregulated in CCA cells. by Wenlong Shen (9313937)

Subjects:

Baseline level biochemical and circulating biomarkers in study subjects. by Jaskiran Kaur (160829)

Subjects:

RBMX depletion leads to significant increase of TERRA level in HeLa cells. by Jingfan Liu (17054762)

Chemicals that increase the expression levels of significant TWAS genes positively associated with UF. by Gayeon Kim (671557)

Effect of different doses of the defatted extract (DE) of the leaves of <i>S. malaccense</i> and <i>S. samarangense</i> on urea and creatinine levels. Data represented as mean±SEM... by Fatma A. Moharram (9276104)

Radiological outcomes: Adjusted mean (standard deviation) ^b'*'. by Seungyoon Paik (14659575)

Subjects:

Adjusted mean values from the mixed-effects model for clinical outcomes. by Seungyoon Paik (14659575)

Subjects:

Clinical outcomes: Adjusted mean (standard deviation) ^b'*'. by Seungyoon Paik (14659575)

Subjects:

Ozone concentration and urbanization level in China, 2015–2019. by Li-Min Wang (783263)

Subjects:

Mean effect of Ag-NPs alone and Ag-NPs + V.E + V.C with respect to dose route and dose levels on hematology of <i>C</i>. <i>idella</i>. by Khalid Javed Iqbal (13833684)

Subjects:

Effect of each software transition and any hardware transition on daily active calories (negative binomial models with a random intercept per participant) among participants with a... by Shelby L. Sturrock (10751675)

Subjects:

Effect of each software transition and any hardware transition on daily minutes of exercise (negative binomial models with a random intercept per participant) among participants wi... by Shelby L. Sturrock (10751675)

Subjects:

Participant characteristics, overall and for each transition, of primary analytic sample (activity data for all 14 days of the respective transition period). by Shelby L. Sturrock (10751675)

Subjects:

Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and post-test (<i>n</i> = 900). by Maria Anna Donati (6735548)

Subjects:

Mean scores compared with paired-samples <i>t</i>-test (and related effect sizes) at pre- and follow-up (<i>n</i> = 662). by Maria Anna Donati (6735548)

Subjects:

Mean Age of hospitalised patients with NC at the INNN (Mexico City) from 1995 to 2019. by Roberto Rodríguez-Rivas (13514430)

Subjects:

Means (±SD) of the psychometric questionnaires of male and female participants with almost no fear, moderate fear and severe fear of COVID-19. by Patrick Nürnberger (12160940)

Subjects:

AZ10606120 treatment significantly increased cytotoxicity and reduced cell number in a dose-dependent manner. by Matthew Drill (22258391)

“…<b>(b)</b> Cytotoxicity quantified via LDH assay of U251 culture supernatants post-treatment. LDH levels were significantly increased in culture supernatants treated with AZ10606120 (50µM) compared to temozolomide (50µM) treatment and untreated controls. …”

Represents the levels of biomarkers as baseline and follow up in placebo and cholecalciferol group. by Jaskiran Kaur (160829)

Subjects: